Developer docs
API playgroundTry for free, no card

Search company profiles

Adhezion Biomedical

Full company profile

uuid000bb9x

Namestring
Adhezion Biomedical
Legal namestring
Adhezion Biomedical
Websiteurl
adhezion.com
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Adhezion Biomedical is a US-based medical device manufacturer founded in 2001, specializing in surgical sealants, tissue adhesives, microbial sealants, catheter securement adhesives, and topical skin adhesives. Its product portfolio includes five branded lines — FloraSeal (microbial sealant), Glubran2 (surgical glue in 0.25ml, 0.5ml, and 1ml volumes), SecurePortIV (catheter securement), SurgiSeal and SurgiSeal Stylus (topical skin adhesives), and Histoacryl — serving clinical use cases spanning wound closure, vascular access, liquid embolics, preoperative sealing, and infection prevention. Manufacturing is conducted at a US facility in Hudson, North Carolina. The company operated as an independent entity for over two decades before being acquired by H.B. Fuller Company in July 2023 and integrated into its Medical Adhesive Technologies division.

The business model is B2B hardware sales of medical-grade adhesive products, sold directly to two customer segments: medical professionals (surgeons, physicians, healthcare providers) and medical device manufacturers requiring adhesive inputs for device assembly, stick-to-skin applications, PPE, and medical filtration. Pricing is quote-based and not publicly disclosed; distribution occurs through direct sales via phone and corporate website, now leveraging H.B. Fuller's global medical adhesive distribution network spanning North America, Europe, and Asia. The target market is the $8 billion healthcare adhesives sector.

Pre-acquisition, the company was venture-backed, having raised approximately $12.3 million across five disclosed financing rounds between 2008 and 2012, with investors including Liberty Venture Partners and Originate Ventures. Following the H.B. Fuller acquisition, Adhezion's product set is positioned within the parent's broader medical adhesive portfolio rather than as an independent growth platform, and standalone financial metrics are no longer separately disclosed.

Short descriptiontext

Adhezion Biomedical is a US-based medical device manufacturer of surgical sealants, tissue adhesives, microbial sealants, catheter securement, and topical skin adhesives, serving medical professionals and medical device manufacturers. Acquired by H.B. Fuller in July 2023.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHudson, United States
HQ citystring
Hudson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical adhesives, surgical sealants, tissue adhesives, wound closure products, catheter securement
Industry2 codes
PRIMARYHLAHALAD
Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYIMAEABAA
Adhesives & Sealants Chemicals
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Adhesive Manufacturing32552
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Adhesives & Sealants2891
Product category
Medical Adhesives
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Adhesive Product Sales
TypeHardware Sales
Description

Adhezion Biomedical generates revenue through the manufacture and sale of surgical sealants, tissue adhesives, and related medical adhesive products to healthcare facilities and medical device manufacturers. Following acquisition by H.B. Fuller, products are sold as part of H.B. Fuller's medical adhesive portfolio targeting the $8 billion healthcare adhesives sector.

openpr.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1H.B. Fuller Medical Adhesive Technologies
Description

A division of H.B. Fuller Company focused on medical-grade adhesive solutions including surgical sealants, tissue adhesives, catheter securement, and wound closure products.

medical.hbfuller.com
Core offering1 text field

Adhezion Biomedical manufactures and sells medical-grade adhesive products for surgical and wound care applications, including microbial sealants (FloraSeal), surgical glues (Glubran2), catheter securement adhesives (SecurePortIV), and topical skin adhesives (SurgiSeal/SurgiSeal Stylus, Histoacryl). The portfolio targets surgical wound closure, vascular access, infection prevention, and medical device assembly applications for medical professionals and medical device manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Acquired by H.B. Fuller in July 2023 to strengthen presence in the $8 billion healthcare adhesives sector
Product overview1 text field

Adhezion Biomedical, acquired by H.B. Fuller in July 2023, operates under H.B. Fuller Medical Adhesive Technologies and offers a portfolio of specialized medical-grade adhesive products. The product lineup centers on surgical sealants and adhesives including FloraSeal (microbial sealant), Glubran2 (surgical glue available in multiple volumes), SecurePortIV (catheter securement adhesive), SurgiSeal and SurgiSeal Stylus (topical skin adhesives), and Histoacryl. These products serve medical professionals in wound closure, vascular access, and infection prevention applications, with the portfolio organized into internal and external medical-grade solutions covering wound closure, vascular access, liquid embolics, and infection control segments.

Product and service6 records
1FloraSeal®
CategorySurgical Sealants
Description

Microbial sealant product designed for medical professionals, providing antimicrobial barrier protection for wound care applications.

2Glubran®2 Surgical Glue
CategorySurgical Adhesives
Description

Surgical glue available in multiple volumes (0.25ml, 0.5ml, 1ml) for tissue sealing and wound closure applications during surgical procedures.

3SecurePortIV®
CategoryCatheter Securement
Description

Catheter securement adhesive designed to safely and effectively secure intravascular catheters, reducing the risk of dislodgement.

4SurgiSeal Stylus®
CategoryTopical Skin Adhesives
Description

Topical skin adhesive delivery device (stylus format) for wound closure, providing a liquid adhesive for superficial wound sealing.

5SurgiSeal®
CategoryTopical Skin Adhesives
Description

Topical skin adhesive product for wound closure, enabling sterile sealing of minor cuts and surgical incisions.

6Histoacryl®
CategoryTissue Adhesives
Description

Medical adhesive product for surgical and wound care applications.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diversified medical products company with skin closure strips, dressings, and medical-grade adhesive solutions. Adjacent competitor to Adhezion's topical adhesives and stick-to-skin applications.

TypeDirect peer
Description

Markets Tisseel and Floseal surgical sealants/hemostats used in operating rooms. Overlaps directly with Adhezion's surgical sealant and tissue adhesive portfolio for internal surgical applications.

TypeDirect peer
Description

Specializes in surgical sealants and hemostats including BioGlue. Competes with Adhezion's Glubran2 and surgical tissue adhesive lines in cardiothoracic and general surgery.

TypeDirect peer
Description

Provides tissue adhesives, dural sealants, and wound care products. Overlaps with Adhezion's surgical sealants (Glubran2, FloraSeal) and catheter securement categories.

TypeDirect peer
Description

Offers surgical tissue adhesives and wound closure products through its Aesculap division. Competes with Adhezion in surgical glues and wound closure solutions for hospitals and surgeons.

TypeDirect peer
Description

Global leader in surgical tissue adhesives and topical skin adhesives (e.g., Dermabond). Directly competes with Adhezion's SurgiSeal and Glubran2 lines across surgical wound closure and topical applications.

TypeDirect peer
Description

Markets Evicel and other surgical sealants/hemostats. Directly competes with Adhezion's surgical sealant portfolio in operating room and vascular applications.

TypeEmerging player
Description

Focused on surgical adhesives and sealants, including tissue adhesives for internal use. Niche overlap with Adhezion's surgical glue portfolio for specific procedural indications.

TypeBroad incumbent
Description

Large diversified wound care and surgical device company offering skin adhesives, dressings, and closure products. Broader portfolio but overlaps with Adhezion's topical skin adhesive and wound closure franchises.

10TissuePatch
TypeEmerging player
Description

Develops tissue adhesives and sealants for surgical applications. Comparable emerging competitor in the surgical sealant space where Adhezion's Glubran2 and FloraSeal compete.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Adhezion Biomedical

Medical Adhesivesadhezion.com

Adhezion Biomedical is a US-based medical device manufacturer of surgical sealants, tissue adhesives, microbial sealants, catheter securement, and topical skin adhesives, serving medical professionals and medical device manufacturers. Acquired by H.B. Fuller in July 2023.

What Adhezion Biomedical does

Adhezion Biomedical is a US-based medical device manufacturer founded in 2001, specializing in surgical sealants, tissue adhesives, microbial sealants, catheter securement adhesives, and topical skin adhesives. Its product portfolio includes five branded lines — FloraSeal (microbial sealant), Glubran2 (surgical glue in 0.25ml, 0.5ml, and 1ml volumes), SecurePortIV (catheter securement), SurgiSeal and SurgiSeal Stylus (topical skin adhesives), and Histoacryl — serving clinical use cases spanning wound closure, vascular access, liquid embolics, preoperative sealing, and infection prevention. Manufacturing is conducted at a US facility in Hudson, North Carolina. The company operated as an independent entity for over two decades before being acquired by H.B. Fuller Company in July 2023 and integrated into its Medical Adhesive Technologies division.

The business model is B2B hardware sales of medical-grade adhesive products, sold directly to two customer segments: medical professionals (surgeons, physicians, healthcare providers) and medical device manufacturers requiring adhesive inputs for device assembly, stick-to-skin applications, PPE, and medical filtration. Pricing is quote-based and not publicly disclosed; distribution occurs through direct sales via phone and corporate website, now leveraging H.B. Fuller's global medical adhesive distribution network spanning North America, Europe, and Asia. The target market is the $8 billion healthcare adhesives sector.

Pre-acquisition, the company was venture-backed, having raised approximately $12.3 million across five disclosed financing rounds between 2008 and 2012, with investors including Liberty Venture Partners and Originate Ventures. Following the H.B. Fuller acquisition, Adhezion's product set is positioned within the parent's broader medical adhesive portfolio rather than as an independent growth platform, and standalone financial metrics are no longer separately disclosed.

Adhezion Biomedical firmographics

Firmographics
Name
Adhezion Biomedical
Legal name
Adhezion Biomedical
Website
https://adhezion.com
Company type
Private
Founded year
2001
Operating status
Acquired
Headcount range
5,001–10,000 employees
Short description
Adhezion Biomedical is a US-based medical device manufacturer of surgical sealants, tissue adhesives, microbial sealants, catheter securement, and topical skin adhesives, serving medical professionals and medical device manufacturers. Acquired by H.B. Fuller in July 2023.
Ownership category
akta.pro rank

Adhezion Biomedical industry classification

Industry
Product category
Medical Adhesives
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Adhesive Manufacturing (32552)
SIC
Surgical & Medical Instruments & Apparatus (3841), Adhesives & Sealants (2891)
akta.pro industry
PRIMARYHLAHALAD
Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYIMAEABAA
Adhesives & Sealants Chemicals

Keywords

  • Medical adhesives
  • Surgical sealants
  • Tissue adhesives
  • Wound closure products
  • Catheter securement

Where Adhezion Biomedical is headquartered

Location

Headquarters

HQ city
Hudson
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Adhezion Biomedical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

  1. Medical Adhesive Product Sales: Adhezion Biomedical generates revenue through the manufacture and sale of surgical sealants, tissue adhesives, and related medical adhesive products to healthcare facilities and medical device manufacturers. Following acquisition by H.B. Fuller, products are sold as part of H.B. Fuller's medical adhesive portfolio targeting the $8 billion healthcare adhesives sector.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Adhezion Biomedical product offering

Product offering

Core offering

Adhezion Biomedical manufactures and sells medical-grade adhesive products for surgical and wound care applications, including microbial sealants (FloraSeal), surgical glues (Glubran2), catheter securement adhesives (SecurePortIV), and topical skin adhesives (SurgiSeal/SurgiSeal Stylus, Histoacryl). The portfolio targets surgical wound closure, vascular access, infection prevention, and medical device assembly applications for medical professionals and medical device manufacturers.

Product overview

Adhezion Biomedical, acquired by H.B. Fuller in July 2023, operates under H.B. Fuller Medical Adhesive Technologies and offers a portfolio of specialized medical-grade adhesive products. The product lineup centers on surgical sealants and adhesives including FloraSeal (microbial sealant), Glubran2 (surgical glue available in multiple volumes), SecurePortIV (catheter securement adhesive), SurgiSeal and SurgiSeal Stylus (topical skin adhesives), and Histoacryl. These products serve medical professionals in wound closure, vascular access, and infection prevention applications, with the portfolio organized into internal and external medical-grade solutions covering wound closure, vascular access, liquid embolics, and infection control segments.

Differentiator

Problem solved

Functional benefit

Brands

  • H.B. Fuller Medical Adhesive Technologies: A division of H.B. Fuller Company focused on medical-grade adhesive solutions including surgical sealants, tissue adhesives, catheter securement, and wound closure products.

Products and services

  • FloraSeal® Microbial sealant product designed for medical professionals, providing antimicrobial barrier protection for wound care applications.
  • Glubran®2 Surgical Glue Surgical glue available in multiple volumes (0.25ml, 0.5ml, 1ml) for tissue sealing and wound closure applications during surgical procedures.
  • SecurePortIV® Catheter securement adhesive designed to safely and effectively secure intravascular catheters, reducing the risk of dislodgement.
  • SurgiSeal Stylus® Topical skin adhesive delivery device (stylus format) for wound closure, providing a liquid adhesive for superficial wound sealing.
  • SurgiSeal® Topical skin adhesive product for wound closure, enabling sterile sealing of minor cuts and surgical incisions.
  • Histoacryl® Medical adhesive product for surgical and wound care applications.

Quantifiable outcome

  • Acquired by H.B. Fuller in July 2023 to strengthen presence in the $8 billion healthcare adhesives sector

Companies that use Adhezion Biomedical

Customer profile

Segments2 records

Ideal customer profiles2 records

Adhezion Biomedical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Adhezion Biomedical partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Adhezion Biomedical competitors and assessment

Company assessment

Broad incumbents

  • 3M Health Care: Diversified medical products company with skin closure strips, dressings, and medical-grade adhesive solutions. Adjacent competitor to Adhezion's topical adhesives and stick-to-skin applications.
  • Smith & Nephew: Large diversified wound care and surgical device company offering skin adhesives, dressings, and closure products. Broader portfolio but overlaps with Adhezion's topical skin adhesive and wound closure franchises.

Direct peers

  • Baxter International: Markets Tisseel and Floseal surgical sealants/hemostats used in operating rooms. Overlaps directly with Adhezion's surgical sealant and tissue adhesive portfolio for internal surgical applications.
  • Artivion (formerly CryoLife): Specializes in surgical sealants and hemostats including BioGlue. Competes with Adhezion's Glubran2 and surgical tissue adhesive lines in cardiothoracic and general surgery.
  • Integra LifeSciences: Provides tissue adhesives, dural sealants, and wound care products. Overlaps with Adhezion's surgical sealants (Glubran2, FloraSeal) and catheter securement categories.
  • B. Braun: Offers surgical tissue adhesives and wound closure products through its Aesculap division. Competes with Adhezion in surgical glues and wound closure solutions for hospitals and surgeons.
  • Ethicon (Johnson & Johnson MedTech): Global leader in surgical tissue adhesives and topical skin adhesives (e.g., Dermabond). Directly competes with Adhezion's SurgiSeal and Glubran2 lines across surgical wound closure and topical applications.
  • Medtronic: Markets Evicel and other surgical sealants/hemostats. Directly competes with Adhezion's surgical sealant portfolio in operating room and vascular applications.

Emerging players

  • Cohera Medical: Focused on surgical adhesives and sealants, including tissue adhesives for internal use. Niche overlap with Adhezion's surgical glue portfolio for specific procedural indications.
  • TissuePatch: Develops tissue adhesives and sealants for surgical applications. Comparable emerging competitor in the surgical sealant space where Adhezion's Glubran2 and FloraSeal compete.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Adhezion Biomedical social profiles

Digital presence

Adhezion Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Adhezion Biomedical leadership team

Management profile

Number of profiles

Profiles3 records

Adhezion Biomedical funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Adhezion Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adhezion Biomedical

What does Adhezion Biomedical do?

Adhezion Biomedical manufactures and sells medical-grade adhesive products for surgical and wound care applications, including microbial sealants (FloraSeal), surgical glues (Glubran2), catheter securement adhesives (SecurePortIV), and topical skin adhesives (SurgiSeal/SurgiSeal Stylus, Histoacryl). The portfolio targets surgical wound closure, vascular access, infection prevention, and medical device assembly applications for medical professionals and medical device manufacturers.

Is Adhezion Biomedical a public or private company?

Adhezion Biomedical is a private company. It is classified as corporate owned and is currently acquired.

When was Adhezion Biomedical founded?

Adhezion Biomedical was founded in 2001. It employs 5,001 to 10,000 people.

Where is Adhezion Biomedical based?

Adhezion Biomedical is headquartered in Hudson, United States, in the North America region.

How does Adhezion Biomedical make money?

One revenue line is on record: medical Adhesive Product Sales.

Who are Adhezion Biomedical's main competitors?

Broad incumbents on record are 3M Health Care and Smith & Nephew. Direct peers are Baxter International, Artivion (formerly CryoLife), Integra LifeSciences, B. Braun, Ethicon (Johnson & Johnson MedTech) and Medtronic. Emerging players are Cohera Medical and TissuePatch.

Does Adhezion Biomedical have an API?

No public API is recorded for Adhezion Biomedical.

What industry is Adhezion Biomedical in?

Adhezion Biomedical's product category is Medical Adhesives. Its primary akta.pro industry code is HLAHALAD, Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips), with a secondary code of IMAEABAA, Adhesives & Sealants Chemicals. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMarket Driver Insights: The Impact of Recent Advancements on the Surgical Sealants and Tissue Patches MarketThe surgical sealants and tissue patches market is projected to reach $4.08 billion by 2030, growing at a compound annual growth rate of 9.7%, driven by the preference for minimally invasive surgeries and advancements in regenerative medicine. In June 2023, H.B. Fuller Company acquired Adhezion Biomedical LLC for $95.8 million to expand its portfolio in healthcare adhesives, surgical sealants, and wound care products. In March 2025, Pramand LLC launched the SpineSeal spine sealant system in the United States following FDA premarket approval, representing a new product innovation in the sector.openPR.comEmerging Growth Patterns Driving the Expansion of the Surgical Sealants and Adhesives MarketThe global surgical sealants and adhesives market is projected to reach $4.99 billion by 2030, expanding at a compound annual growth rate of 11.0%, driven by increasing demand for minimally invasive surgical techniques, faster patient recovery times, and growing investments in advanced biomaterials. In July 2023, H.B. Fuller Company acquired Adhezion Biomedical, a US-based manufacturer of surgical sealants and adhesives, in a strategic move to bolster H.B. Fuller's presence in the $8 billion healthcare adhesives sector. Additionally, Animus Surgical launched Membra, a biodegradable hydrogel wound sealant, in March 2023, highlighting ongoing innovation in bio-based wound closure products.Business Wire BlogH.B. Fuller Completes Strategic Acquisitions Consistent with Profitable Growth StrategyH.B. Fuller completed acquisitions of Adhezion Biomedical and XCHEM International to expand its adhesives portfolio. The deals are expected to add $60 million in revenue and $15 million in adjusted EBITDA by fiscal 2025, with $17 million and $2 million respectively in fiscal 2023.Knowledge at WhartonShu Yang Wins Manufacturing PA Innovation Grant for Developing Snail-inspired AdhesiveProfessor Shu Yang has been awarded a $70,000 Manufacturing PA Innovation grant to develop a snail-inspired hydrogel adhesive for medical wound closure. The project involves collaboration with Lehigh University and Adehzion Biomedical to create a biocompatible film that hardens upon contact with wound fluids.PR NewswireAdhezion Biomedical introduces SecurePortIV™, a new standard in the securement and site protection of vascular access devicesAdhezion Biomedical announced FDA 510(k) clearance of SecurePortIV™, a cyanoacrylate-based catheter securement adhesive designed to enhance device securement, seal catheter insertion sites, protect patients from bloodstream infections, and provide a water-resistant barrier. The product is applied under the catheter hub and over the insertion site, forming a film that reduces catheter movement while sealing against bacteria and fungi. CEO Pete Molinaro highlighted that SecurePortIV™ is the only FDA-cleared cyanoacrylate adhesive for vascular access devices, potentially simplifying catheter care while reducing the need for multiple securement products.PR NewswireAdhezion Biomedical Announces Distribution Agreement with OsteoRemediesAdhezion Biomedical signed a distribution agreement with OsteoRemedies granting exclusive distribution rights for FLORASEAL Microbial Sealant in the United States. FLORASEAL is a patented film-forming, cyanoacrylate-based microbial sealant designed to reduce skin flora contamination during surgical procedures and typically adheres to skin for 5-7 days. Adhezion CEO Pete Molinaro emphasized the product's potential for surgical site infection prevention and expressed confidence in OsteoRemedies' distribution capabilities.